| mRNA |
BRD-K51490254 |
CTRPv2 |
pan-cancer |
AAC |
-0.0072 |
0.8 |
| mRNA |
BRD-K24690302 |
CTRPv2 |
pan-cancer |
AAC |
0.007 |
0.8 |
| mRNA |
WZ-1-84 |
GDSC1000 |
pan-cancer |
AAC |
-0.011 |
0.8 |
| mRNA |
GSK-1904529A |
GDSC1000 |
pan-cancer |
AAC |
0.0065 |
0.9 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0067 |
0.9 |
| mRNA |
AP-24534 |
GDSC1000 |
pan-cancer |
AAC |
-0.0064 |
0.9 |
| mRNA |
Irinotecan |
CCLE |
pan-cancer |
AAC |
0.01 |
0.9 |
| mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0064 |
0.9 |
| mRNA |
BRD-M00053801 |
CTRPv2 |
pan-cancer |
AAC |
-0.0086 |
0.9 |
| mRNA |
HC-067047 |
CTRPv2 |
pan-cancer |
AAC |
-0.0068 |
0.9 |